← UNITED THERAPEUTICS Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $1.0b | $705.1m | $669.2m | $738.4m | $738.7m | $894.8m | $961.2m | $1.2b | $1.7b | $1.6b | |
| Inventory, Net | $100.0m | $107.9m | $101.0m | $93.4m | $86.5m | $93.8m | $102.0m | $111.8m | $157.9m | $183.1m | |
| Assets, Current | $1.4b | $1.4b | $1.8b | $1.9b | $2.2b | $2.3b | $3.4b | $3.6b | $3.9b | $3.7b | |
| Property, Plant and Equipment, Net | $489.3m | $545.7m | $699.7m | $738.5m | $731.6m | $780.9m | $861.5m | $1.0b | $1.2b | $1.7b | |
| Goodwill | $10.3m | $13.7m | $31.5m | $28.0m | $28.0m | $28.0m | $28.0m | $33.7m | $32.3m | $32.3m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $4.8m | — | — | — | — | — | — | |
| Other Assets, Noncurrent | $197.1m | $224.1m | $224.2m | $154.6m | $169.9m | $108.2m | $114.3m | $151.8m | $222.1m | $196.9m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $214.5m | $297.1m | $175.7m | $151.4m | $157.4m | $198.7m | $220.4m | $278.9m | $279.3m | $350.2m | |
| Accrued Liabilities, Current | $96.1m | $162.7m | $143.0m | $138.5m | $182.9m | $170.8m | $225.8m | $292.4m | $338.5m | $480.9m | |
| Assets | $2.3b | $2.9b | $3.4b | $3.9b | $4.6b | $5.2b | $6.0b | $7.2b | $7.4b | $7.9b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $1.8m | — | — | — | — | — | — | |
| Accounts Payable, Current | $8.1m | $8.4m | $23.1m | $9.9m | $4.1m | $3.8m | $4.1m | $5.6m | $6.0m | $7.1m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $3.0m | — | — | — | — | — | — | |
| Liabilities, Current | $332.5m | $444.7m | $276.6m | $463.0m | $323.3m | $305.4m | $343.2m | $804.4m | $738.1m | $560.6m | |
| Other Liabilities, Noncurrent | $130.9m | $63.7m | $66.6m | $70.0m | $96.5m | $104.8m | $104.6m | $77.8m | $181.9m | $223.2m | |
| Liabilities | $463.4m | $758.4m | $593.2m | $1.1b | $1.2b | $1.2b | $1.2b | $1.2b | $920.0m | $783.8m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $700k | $700k | $700k | $700k | $700k | $700k | $700k | $700k | $800k | $800k | |
| Retained Earnings (Accumulated Deficit) | $2.4b | $2.8b | $3.4b | $3.3b | $3.8b | $4.3b | $5.0b | $6.0b | $7.2b | $8.6b | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($16.8m) | ($19.6m) | ($7.9m) | ($14.2m) | ($14.2m) | ($23.0m) | ($55.5m) | ($12.8m) | ($3.4m) | $900k | |
| Additional Paid in Capital, Common Stock | $1.8b | $1.9b | $1.9b | $2.0b | $2.1b | $2.2b | $2.4b | $2.5b | $2.7b | $2.8b | |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | ($16.8m) | ($19.6m) | ($7.9m) | ($14.2m) | ($14.2m) | $500k | ($18.8m) | ($15.9m) | ($11.0m) | ($5.6m) | |
| Stockholders' Equity Attributable to Parent | $1.9b | $2.1b | $2.8b | $2.8b | $3.4b | $4.0b | $4.8b | $6.0b | $6.4b | $7.1b | |
| Liabilities and Equity | $2.3b | $2.9b | $3.4b | $3.9b | $4.6b | $5.2b | $6.0b | $7.2b | $7.4b | $7.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.